PRESS RELEASE published on 06/24/2025 at 22:15, 10 months 18 days ago Jaguar Health Announces Extension of the Maturity Date of its Convertible Promissory Notes from Recently Closed Bridge Financing to January 30, 2026 Jaguar Health, Inc. extends maturity date of convertible promissory notes in bridge financing. CEO Lisa Conte appreciates investors' support for core programs Bridge Financing Jaguar Health Lisa Conte Promissory Notes Core Programs
PRESS RELEASE published on 06/24/2025 at 22:12, 10 months 18 days ago Inside Information / Other news releases Vinpai announces delay in the acquisition of a majority stake by Camlin Fine Science Limited due to technical requirements completion. New timetable aims for completion by mid-September Acquisition Stake Delay Vinpai Camlin Fine Science Limited
PRESS RELEASE published on 06/24/2025 at 22:12, 10 months 18 days ago Informations privilégiées / Autres communiqués Vinpai annonce le report du calendrier d'acquisition par Camlin Fine Science Limited pour finaliser des démarches administratives. Acquisition prévue mi-septembre Acquisition Vinpai Camlin Fine Science Limited Ingrédients Fonctionnels Report Du Calendrier
PRESS RELEASE published on 06/24/2025 at 22:09, 10 months 18 days ago CureVac Announces Voting Results of General Meeting CureVac announces voting results of Annual General Meeting, including new Management Board and Supervisory Board appointments. KPMG reappointed as external auditors Annual General Meeting Appointments Voting Results KPMG CureVac
PRESS RELEASE published on 06/24/2025 at 21:40, 10 months 18 days ago Dateline Resources Announces $1 Million Investment from Managing Director Stephen Baghdadi Managing Director of Dateline Resources invests over $1.06 million, boosting confidence in Colosseum Project and rare earth elements exploration in California Rare Earth Elements Investment California Dateline Resources Colosseum Project
PRESS RELEASE published on 06/24/2025 at 20:00, 10 months 18 days ago Informations privilégiées / Autres communiqués MaaT Pharma présente les résultats de son Assemblée Générale ordinaire annuelle et extraordinaire avec un quorum dépassant 73%. Résolutions approuvées concernant les comptes et la gouvernance Gouvernance Assemblée Générale Résultats MaaT Pharma Comptes
PRESS RELEASE published on 06/24/2025 at 20:00, 10 months 18 days ago Inside Information / Other news releases MaaT Pharma presents Annual General Meeting results, with shareholders approving most resolutions. Jean-Marie Lefevre appointed Chairman. Liquidity contract with Kepler Cheuvreux maintained Annual General Meeting Shareholders Liquidity Contract MaaT Pharma Jean-Marie Lefevre
PRESS RELEASE published on 06/24/2025 at 19:50, 10 months 18 days ago Strong demand for Formycon 2025/2029 Bond leads to early closing of subscription period Formycon AG experiences high demand for its 2025/2029 Bond, leading to an early closure of the subscription period. Institutional investors show significant interest in the bond Institutional Investors Formycon AG Financial Flexibility Subscription Period 2025/2029 Bond
PRESS RELEASE published on 06/24/2025 at 19:25, 10 months 18 days ago Gleason & Sons Increases Its Holdings in Elemental Altus Royalties After Tether's Investment, Expanded Revenues Gleason & Sons LLC acquires one million shares of Elemental Altus Royalties Corp., positioning for growth in mining royalty space Acquisition Investment Gleason & Sons LLC Mining Royalty Elemental Altus
PRESS RELEASE published on 06/24/2025 at 19:00, 10 months 18 days ago AstroNova's Board Stonewalls Meaningful Change AstroNova breached confidentiality and misrepresented private negotiations, leading to a breakdown in engagement with shareholders. Board prioritizes entrenchment over shareholder concerns Shareholder Concerns AstroNova Confidentiality Breach Proxy Contest Board Entrenchment
Published on 05/13/2026 at 15:30, 2 hours 32 minutes ago All Things Mobile Analytic, Inc. (OTCID:ATMH) Acquires Metis Technology S.p.A., Strengthening European Enterprise Capabilities
Published on 05/13/2026 at 15:05, 2 hours 57 minutes ago Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services
Published on 05/13/2026 at 15:00, 3 hours 2 minutes ago ACCESS Newswire to Present at the LD Micro Invitational XVI on May 19th, at 2:00 pm ET
Published on 05/13/2026 at 15:00, 3 hours 2 minutes ago Caldwell Announces Relaunch of Canada's Top 40 Under 40(R) Award Program
Published on 05/13/2026 at 14:35, 3 hours 27 minutes ago INEO Announces Patented INEO Welcoming DUO in Full Production with First Installation Underway in Leading UK Retailer
Published on 05/13/2026 at 17:40, 21 minutes ago NR21: Communiqué sur les modalités de mise à disposition des documents préparatoires à l’AGM du 4 juin 2026
Published on 05/13/2026 at 17:20, 41 minutes ago Uzin Utz SE: Annual General Meeting approves dividend for the 2025 fiscal year
Published on 05/13/2026 at 16:50, 1 hour 11 minutes ago Piramal Pharma Solutions Unveils State-of-the-Art Payload-Linker Suite at its Riverview, Michigan Facility
Published on 05/13/2026 at 16:05, 1 hour 56 minutes ago PR Emerges as the Primary Source for Journalists in High-Pressure Newsrooms
Published on 05/13/2026 at 16:05, 1 hour 56 minutes ago Coupa and Celonis Collaborate to Eliminate Value Leakage Across Autonomous Spend Management
Published on 05/13/2026 at 18:00, 2 minutes ago ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires
Published on 05/13/2026 at 17:45, 17 minutes ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
Published on 05/13/2026 at 17:45, 17 minutes ago Infotel confirme son retour à la croissance au 1 er trimestre 2026 avec un chiffre d’affaires en progression de + 8,6 %. Proposition d’un dividende de 2 € par action au titre de 2025.
